Taysha Gene Therapies Stock Price History

Below is the normalized historical share price chart for Taysha Gene Therapies extending back to September 24, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Taysha Gene stands at 3.24, as last reported on the 2nd of December, with the highest price reaching 3.30 and the lowest price hitting 3.00 during the day. If you're considering investing in Taysha Stock, it is important to understand the factors that can impact its price. Taysha Gene appears to be dangerous, given 3 months investment horizon. Taysha Gene Therapies owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had a 0.12% return per unit of risk over the last 3 months. By inspecting Taysha Gene's technical indicators, you can evaluate if the expected return of 0.98% is justified by implied risk. Please review Taysha Gene's Coefficient Of Variation of 845.84, risk adjusted performance of 0.0994, and Semi Deviation of 4.58 to confirm if our risk estimates are consistent with your expectations. At present, Taysha Gene's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to 2,100, whereas Total Stockholder Equity is forecasted to decline to about 67.6 M. . At present, Taysha Gene's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.03, whereas Price To Sales Ratio is forecasted to decline to 12.64. Taysha Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1234

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns				TSHA
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

Expected Return

Risk-Adjusted Return